Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

MAMMALIAN PHENOTYPE - ANNOTATIONS

The Mouse Adult Gross Anatomy Ontology and Mammalian Phenotype Ontology are downloaded weekly from the Mouse Genome Informatics databases at Jackson Laboratories (ftp://ftp.informatics.jax.org/pub/reports/index.html). For more information about these ontologies, see the MGI Publications Page at http://www.informatics.jax.org/mgihome/other/publications.shtml.

Term:increased carcinoma incidence
go back to main search page
Accession:MP:0002038 term browser browse the term
Definition:greater than the expected number of any of a variety of malignant neoplasms arising from epithelial cells, occurring in a specific population in a given time period; carcinomas are usually glandular or squamous in origin
Synonyms:related_synonym: carcinoma


show annotations for term's descendants           Sort by:
 
increased endometrial carcinoma incidence term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Edcs1 Endometrial carcinoma susceptibility QTL1 susceptibility IDA RGD PMID:11745480 RGD:1599856 NCBI chr11:19,016,272...25,069,932 JBrowse link
Q Edcs2 Endometrial carcinoma susceptibility QTL2 susceptibility IDA RGD PMID:11745480 RGD:1599856 NCBI chr12:8,249,608...20,590,080 JBrowse link
Q Edcs3 Endometrial carcinoma susceptibility QTL3 susceptibility IDA RGD PMID:11745480 RGD:1599856 NCBI chr20:1...25,653,396 JBrowse link
Q Edcs4 Endometrial carcinoma susceptibility QTL 4 susceptibility IDA RGD PMID:11745480 RGD:1599856 NCBI chr 1:226,706,329...271,706,329 JBrowse link
Q Edcs5 Endometrial carcinoma susceptibility QTL 5 susceptibility IDA RGD PMID:11745480 RGD:1599856 NCBI chr17:62,195,703...74,702,206 JBrowse link
increased hepatocellular carcinoma incidence term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcas1 Hepatocarcinoma susceptibility QTL 1 IDA RGD PMID:10493520 RGD:619598 NCBI chr 7:100,160,423...140,335,001 JBrowse link
Q Hcas2 Hepatocarcinoma susceptibility QTL 2 IDA RGD PMID:10493520 RGD:619598 NCBI chr 1:5,655,769...122,614,963 JBrowse link
increased mammary adenocarcinoma incidence term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Emca1 Estrogen-induced mammary cancer QTL 1 IAGP RGD PMID:15611180 RGD:1358124 NCBI chr 5:102,945,579...154,732,228 JBrowse link
Q Emca11 Estrogen-induced mammary cancer QTL 11 IDA RGD PMID:23151807 RGD:7364727 NCBI chr 5:103,580,245...117,037,276 JBrowse link
Q Emca12 Estrogen-induced mammary cancer QTL 12 IDA RGD PMID:23151807 RGD:7364727 NCBI chr 5:129,038,716...139,099,229 JBrowse link
Q Emca13 Estrogen-induced mammary cancer QTL 13 IDA RGD PMID:23151807 RGD:7364727 NCBI chr 5:9,514,842...103,580,403 JBrowse link
Q Emca2 Estrogen-induced mammary cancer QTL 2 IAGP RGD PMID:15611180 RGD:1358124 NCBI chr18:19,031,030...68,436,105 JBrowse link
Q Emca4 Estrogen-induced mammary cancer QTL 4 susceptibility IDA estrogen induced RGD PMID:16885383 RGD:1642522 NCBI chr 7:69,399,586...111,043,530 JBrowse link
Q Emca5 Estrogen-induced mammary cancer QTL 5 susceptibility IDA estrogen induced RGD PMID:16885383 RGD:1642522 NCBI chr 3:45,406,058...177,699,992 JBrowse link
Q Emca6 Estrogen-induced mammary cancer QTL 6 susceptibility IDA estrogen induced RGD PMID:16885383 RGD:1642522 NCBI chr 4:43,414,605...155,469,929 JBrowse link
Q Emca7 Estrogen-induced mammary cancer QTL 7 IDA estrogen induced RGD PMID:16885383 RGD:1642522 NCBI chr 6:2,537,030...111,715,717 JBrowse link
Q Emca8 Estrogen-induced mammary cancer QTL 8 susceptibility IDA estrogen induced RGD PMID:16885383 RGD:1642522 NCBI chr 5:51,418,671...147,487,820 JBrowse link
Q Mamtr5 Mammary tumor resistance QTL 5 IDA RGD PMID:17230524 RGD:1599390 NCBI chr 5:18,847,913...63,847,913 JBrowse link
Q Mamtr6 Mammary tumor resistance QTL 6 IDA RGD PMID:17230524 RGD:1599390 NCBI chr18:20,285,758...87,080,053 JBrowse link
Q Mamtr7 Mammary tumor resistance QTL 7 IDA RGD PMID:19052818 RGD:2302423 NCBI chr10:9,841,807...108,540,162 JBrowse link
Q Mamtr8 Mammary tumor resistance QTL 8 IDA RGD PMID:19052818 RGD:2302423 NCBI chr18:32,670,352...87,080,053 JBrowse link
Q Mcs1 Mammary carcinoma susceptibility QTL 1 QTM RGD PMID:8168109 RGD:61080 NCBI chr 2:5,417,336...21,657,459 JBrowse link
Q Mcs15 Mammary carcinoma susceptibility QTL 15 IAGP RGD PMID:16568087 RGD:1581951 NCBI chr10:88,544,136...107,545,372 JBrowse link
Q Mcs16 Mammary carcinoma susceptibility QTL 16 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 1:1,868,045...43,724,576 JBrowse link
Q Mcs17 Mammary carcinoma susceptibility QTL 17 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 1:215,684,498...260,684,498 JBrowse link
Q Mcs18 Mammary carcinoma susceptibility QTL 18 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 2:5,417,336...42,777,046 JBrowse link
Q Mcs19 Mammary carcinoma susceptibility QTL 19 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 5:103,265,614...107,119,704 JBrowse link
Q Mcs2 Mammary carcinoma susceptibility QTL 2 QTM RGD PMID:9584103 RGD:61081 NCBI chr 7:24,738,680...40,433,335 JBrowse link
Q Mcs20 Mammary carcinoma susceptibility QTL 20 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 9:15,554,901...47,249,201 JBrowse link
Q Mcs21 Mammary carcinoma susceptibility QTL 21 IDA RGD PMID:16596452 RGD:1599317 NCBI chr10:30,021,354...54,057,745 JBrowse link
Q Mcs22 Mammary carcinoma susceptibility QTL 22 IDA RGD PMID:16596452 RGD:1599317 NCBI chr18:54,108,375...68,819,562 JBrowse link
Q Mcs23 Mammary carcinoma susceptibility QTL 23 IDA RGD PMID:17404222 RGD:1601189
Q Mcs24 Mammary carcinoma susceptibility QTL 24 IDA RGD PMID:17404222 RGD:1601189 NCBI chr 5:68,838,385...113,838,385 JBrowse link
Q Mcs26 Mammary carcinoma susceptibility QTL 26 IDA DMBA induced RGD PMID:20737482 RGD:4143380 NCBI chr 6:111,134,524...138,065,254 JBrowse link
Q Mcs27 Mammary carcinoma susceptibility QTL 27 IDA DMBA induced RGD PMID:20737482 RGD:4143380 NCBI chr13:48,776,655...53,264,877 JBrowse link
Q Mcs3 Mammary carcinoma susceptibility QTL 3 QTM RGD PMID:9584103 RGD:61081 NCBI chr 1:108,057,233...167,517,487 JBrowse link
Q Mcs4 Mammary carcinoma susceptibility QTL 4 QTM RGD PMID:9584103 RGD:61081 NCBI chr 8:20,717,592...65,717,592 JBrowse link
Q Mcs5 Mammary carcinoma susceptibility QTL 5 QTM RGD PMID:11139513 RGD:62417 NCBI chr 5:56,991,667...137,729,065 JBrowse link
Q Mcs6 Mammary carcinoma susceptibility QTL 6 QTM RGD PMID:11139513 RGD:62417 NCBI chr 7:33,044,449...71,352,127 JBrowse link
Q Mcs7 Mammary carcinoma susceptibility QTL 7 QTM RGD PMID:11139513 RGD:62417 NCBI chr10:75,544,754...112,626,471 JBrowse link
Q Mcs8 Mammary carcinoma susceptibility QTL 8 QTM RGD PMID:11139513 RGD:62417 NCBI chr14:4,833,233...26,466,248 JBrowse link
Q Mcsm1 Mammary carcinoma susceptibility modifier QTL 1 QTM RGD PMID:11139513 RGD:62417 NCBI chr 6:62,263,348...107,263,348 JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  mammalian phenotype 5006
    neoplasm 229
      altered tumor susceptibility 222
        abnormal tumor incidence 211
          abnormal classified tumor incidence 102
            increased classified tumor incidence 102
              increased malignant tumor incidence 61
                increased carcinoma incidence 59
                  increased adenocarcinoma incidence + 49
                  increased basal cell carcinoma incidence 0
                  increased cholangiocarcinoma incidence 0
                  increased endometrial carcinoma incidence 5
                  increased hepatocellular carcinoma incidence 3
                  increased lung carcinoma incidence + 0
                  increased mammary gland ductal carcinoma incidence 0
                  increased ovarian carcinoma incidence 0
                  increased pancreatic islet cell carcinoma incidence 0
                  increased renal carcinoma incidence 0
                  increased spindle cell carcinoma incidence 0
                  increased squamous cell carcinoma incidence + 0
                  increased teratocarcinoma incidence 0
                  increased thyroid carcinoma incidence + 0
                  increased urinary bladder carcinoma incidence + 0
                  increased uterus carcinoma incidence 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.